These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4040729)

  • 1. [Prostatic osteocondensing metastases. The value of examining for osteomalacia].
    Mage P; Coindre JM; Goussot JF; Ballanger P; Lamarche P
    Ann Urol (Paris); 1985; 19(3):203-6. PubMed ID: 4040729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostatic osteocondensing metastases and osteomalacia. Value of histomorphometric study. Preliminary results].
    Coindre JM; Mage P; Bui BN; Goussot JF; De Mascarel I; De Mascarel A; Trojani M
    Presse Med; 1985 Oct; 14(35):1823-7. PubMed ID: 2933667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitamin-sensitive osteomalacia in condensing bone metastases of prostatic origin. Apropos of 2 cases].
    Charhon S; Rouillat M; Bouvier M; Meunier PJ; Lejeune E
    Rev Rhum Mal Osteoartic; 1981 Jun; 48(6):469-76. PubMed ID: 7256162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A man with osteoblastic metastasis and hypocalcaemia.
    Lim SC; Tan CE; Aw TC; Khoo D; Eng P; Ho SC; Tai ES; Fok A
    Singapore Med J; 2000 Feb; 41(2):74-6. PubMed ID: 11063207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteomalacia associated with prostatic cancer and osteoblastic metastases.
    Kabadi UM
    Urology; 1983 Jan; 21(1):65-7. PubMed ID: 6687413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dense bone metastases and hypophosphatemic osteomalacia during the course of prostatic cancer (author's transl)].
    Quilichini R; Aubert L; Chauvin M; Chaffanjon P; Eisinger J
    Sem Hop; 1979 Dec 18-25; 55(43-44):2037-9. PubMed ID: 233449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone metastasis with osteomalacia in cancer of the prostate. 2 cases].
    Delbarre F; Ghozlan R; Amor B
    Nouv Presse Med; 1975 Apr; 4(17):1277-8. PubMed ID: 168553
    [No Abstract]   [Full Text] [Related]  

  • 8. Sclerotic bone metastases of prostatic origin and osteomalacia. Importance of a histomorphometry study.
    Bürki F; Coindre JM; Mauriac L
    Prog Clin Biol Res; 1987; 243A():569-71. PubMed ID: 3659014
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinction between focally accelerated bone formation and osteomalacia in carcinoma of prostate metastasised to bone.
    Taube T; Beneton MN; Williams JL; McCloskey EV; Kanis JA
    Br J Urol; 1993 Jul; 72(1):98-103. PubMed ID: 8149187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteomalacia in the metastatic region of prostatic origin resistant to vitamin and calcium therapy. Role of hypomagnesemia].
    Le Loët X; Ducastelle C; Hemet J; Deshayes P
    Rev Rhum Mal Osteoartic; 1983 Feb; 50(2):141-4. PubMed ID: 6857127
    [No Abstract]   [Full Text] [Related]  

  • 11. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia.
    Charhon SA; Chapuy MC; Delvin EE; Valentin-Opran A; Edouard CM; Meunier PJ
    Cancer; 1983 Mar; 51(5):918-24. PubMed ID: 6681595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumor-induced osteomalacia on the bone mineralization process.
    Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
    Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological and histological profile of osteomalacia in condensing prostatic osteosis. Apropos of 4 cases].
    Franck JL; Bouteiller G; Fauchier C; Sarramon JP; Arlet J
    Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):81-5. PubMed ID: 6801753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncogenic osteomalacia: its pathogenesis, clinical picture and treatment].
    Ermolenko VM; Melikaian AM; Shotemor ShSh; Potapova AV
    Ter Arkh; 1995; 67(5):58-61. PubMed ID: 7638783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biphosphonates in the treatment of bone metastasis of prostatic cancer].
    Paule B; Cicco A
    Prog Urol; 2001 Dec; 11(6):1205-12. PubMed ID: 11859653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum alkaline phosphatase flare in prostate cancer accompanied by bone metastases and treated with hormonal therapy. TEKK Study Group].
    Taue R; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1999 Oct; 45(10):681-5. PubMed ID: 10586358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of bone turnover for the management of patients with bone metastases from prostate cancer.
    Garnero P; Buchs N; Zekri J; Rizzoli R; Coleman RE; Delmas PD
    Br J Cancer; 2000 Feb; 82(4):858-64. PubMed ID: 10732759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of spine surgeons on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis.
    Dipaola CP; Bible JE; Biswas D; Dipaola M; Grauer JN; Rechtine GR
    Spine J; 2009 Jul; 9(7):537-44. PubMed ID: 19328744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteomalacia in prostatic condensing osteosis with normal levels of 1-25 OH2 D3].
    Bouvier M; Bonvoisin B; Paupert-Ravault A; Lejeune E
    Nouv Presse Med; 1981 Nov; 10(42):3493-4. PubMed ID: 6895551
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncogenic osteomalacia: muscular weakness and multiple fractures.
    Ladha SS; Whitaker MD; Bosch EP
    Neurology; 2006 Jul; 67(2):364-5. PubMed ID: 16864847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.